Literature DB >> 19688182

Transient alterations of creatine, creatine phosphate, N-acetylaspartate and high-energy phosphates after mild traumatic brain injury in the rat.

Stefano Signoretti1, Valentina Di Pietro, Roberto Vagnozzi, Giuseppe Lazzarino, Angela M Amorini, Antonio Belli, Serafina D'Urso, Barbara Tavazzi.   

Abstract

In this study, the concentrations of creatine (Cr), creatine phosphate (CrP), N-acetylaspartate (NAA), ATP, ADP and phosphatidylcholine (PC) were measured at different time intervals after mild traumatic brain injury (mTBI) in whole brain homogenates of rats. Anaesthetized animals underwent to the closed-head impact acceleration "weight-drop" model (450 g delivered from 1 m height = mild traumatic brain injury) and were killed at 2, 6, 24, 48 and 120 h after the insult (n = 6 for each time point). Sham-operated rats (n = 6) were used as controls. Compounds of interest were synchronously measured by HPLC in organic solvent deproteinized whole brain homogenates. A reversible decrease of all metabolites but PC was observed, with minimal values recorded at 24 h post-injury (minimum of CrP = 48 h after impact). In particular, Cr and NAA showed a decrease of 44.5 and 29.5%, respectively, at this time point. When measuring NAA in relation to other metabolites, as it is commonly carried out in "in vivo" (1)H-magnetic resonance spectroscopy ((1)H-MRS), an increase in the NAA/Cr ratio and a decrease in the NAA/PC ratio was observed. Besides confirming a transient alteration of NAA homeostasis and ATP imbalance, our results clearly show significant changes in the cerebral concentration of Cr and CrP after mTBI. This suggests a careful use of the NAA/Cr ratio to measure NAA by (1)H-MRS in conditions of altered cerebral energy metabolism. Viceversa, the NAA/PC ratio appears to be a better indicator of actual NAA levels during energy metabolism impairment. Furthermore, our data suggest that, under pathological conditions affecting the brain energetic, the Cr-CrP system is not a suitable tool to buffer possible ATP depletion in the brain, thus supporting the growing indications for alternative roles of cerebral Cr.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688182     DOI: 10.1007/s11010-009-0228-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  53 in total

1.  ATP and phosphocreatine changes in single human muscle fibers after intense electrical stimulation.

Authors:  K Söderlund; E Hultman
Journal:  Am J Physiol       Date:  1991-12

2.  X-linked creatine transporter deficiency: clinical description of a patient with a novel SLC6A8 gene mutation.

Authors:  Maria C Schiaffino; Carlo Bellini; Laura Costabello; Ubaldo Caruso; Cornelis Jakobs; Gajja S Salomons; Eugenio Bonioli
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

3.  Influence of sprint training on human skeletal muscle purine nucleotide metabolism.

Authors:  C G Stathis; M A Febbraio; M F Carey; R J Snow
Journal:  J Appl Physiol (1985)       Date:  1994-04

4.  Creatine phosphate as the preferred early indicator of ischemia in muscular tissues.

Authors:  J Ye; M G Clark; E Q Colquhoun
Journal:  J Surg Res       Date:  1996-02-15       Impact factor: 2.192

5.  Early proton magnetic resonance spectroscopy in normal-appearing brain correlates with outcome in patients following traumatic brain injury.

Authors:  M R Garnett; A M Blamire; R G Corkill; T A Cadoux-Hudson; B Rajagopalan; P Styles
Journal:  Brain       Date:  2000-10       Impact factor: 13.501

6.  Mild head injury increasing the brain's vulnerability to a second concussive impact.

Authors:  H L Laurer; F M Bareyre; V M Lee; J Q Trojanowski; L Longhi; R Hoover; K E Saatman; R Raghupathi; S Hoshino; M S Grady; T K McIntosh
Journal:  J Neurosurg       Date:  2001-11       Impact factor: 5.115

7.  Temporal window of metabolic brain vulnerability to concussions: mitochondrial-related impairment--part I.

Authors:  Roberto Vagnozzi; Barbara Tavazzi; Stefano Signoretti; Angela M Amorini; Antonio Belli; Marco Cimatti; Roberto Delfini; Valentina Di Pietro; Antonino Finocchiaro; Giuseppe Lazzarino
Journal:  Neurosurgery       Date:  2007-08       Impact factor: 4.654

8.  Aging impairs functional, metabolic and ionic recovery from ischemia-reperfusion and hypoxia-reoxygenation.

Authors:  J P Headrick
Journal:  J Mol Cell Cardiol       Date:  1998-07       Impact factor: 5.000

9.  A new model of diffuse brain injury in rats. Part II: Morphological characterization.

Authors:  M A Foda; A Marmarou
Journal:  J Neurosurg       Date:  1994-02       Impact factor: 5.115

10.  X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8.

Authors:  Alberto Bizzi; Marianna Bugiani; Gajja S Salomons; Donald H Hunneman; Isabella Moroni; Margherita Estienne; Ugo Danesi; Cornelis Jakobs; Graziella Uziel
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

View more
  24 in total

1.  Ketogenic diet prevents alterations in brain metabolism in young but not adult rats after traumatic brain injury.

Authors:  Ying Deng-Bryant; Mayumi L Prins; David A Hovda; Neil G Harris
Journal:  J Neurotrauma       Date:  2011-08-04       Impact factor: 5.269

2.  Cerebral Energy Status and Altered Metabolism in Early Severe TBI: First Results of a Prospective 31P-MRS Feasibility Study.

Authors:  Daniel Pinggera; Ruth Steiger; Marlies Bauer; Johannes Kerschbaumer; Markus Luger; Ronny Beer; Andreas Rietzler; Astrid E Grams; Elke R Gizewski; Claudius Thomé; Ondra Petr
Journal:  Neurocrit Care       Date:  2021-04       Impact factor: 3.210

3.  S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury.

Authors:  Valentina Di Pietro; Angela Maria Amorini; Giacomo Lazzarino; Kamal Makram Yakoub; Serafina D'Urso; Giuseppe Lazzarino; Antonio Belli
Journal:  Neurochem Res       Date:  2015-04-22       Impact factor: 3.996

4.  Whole-brain proton MR spectroscopic imaging of mild-to-moderate traumatic brain injury and correlation with neuropsychological deficits.

Authors:  Varan Govind; Stuart Gold; Krithica Kaliannan; Gaurav Saigal; Steven Falcone; Kristopher L Arheart; Leo Harris; Jonathan Jagid; Andrew A Maudsley
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

5.  Prognostic factor from MR spectroscopy in rat with astrocytic tumour during radiation therapy.

Authors:  T G Yu; Y Feng; X Y Feng; J Z Dai; H J Qian; Z Huang
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

6.  The use of magnetic resonance spectroscopy in the subacute evaluation of athletes recovering from single and multiple mild traumatic brain injury.

Authors:  Brian Johnson; Michael Gay; Kai Zhang; Thomas Neuberger; Silvina G Horovitz; Mark Hallett; Wayne Sebastianelli; Semyon Slobounov
Journal:  J Neurotrauma       Date:  2012-08-17       Impact factor: 5.269

7.  Brain core temperature of patients with mild traumatic brain injury as assessed by DWI-thermometry.

Authors:  Jun Tazoe; Kei Yamada; Koji Sakai; Kentaro Akazawa; Katsuyoshi Mineura
Journal:  Neuroradiology       Date:  2014-07-12       Impact factor: 2.804

8.  Effects of Blast Exposure on Subjective and Objective Sleep Measures in Combat Veterans with and without PTSD.

Authors:  Ryan P J Stocker; Benjamin T E Paul; Oommen Mammen; Hassen Khan; Marissa A Cieply; Anne Germain
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

9.  Impact of reduced k-space acquisition on pathologic detectability for volumetric MR spectroscopic imaging.

Authors:  Mohammad Sabati; Jiping Zhan; Varan Govind; Kristopher L Arheart; Andrew A Maudsley
Journal:  J Magn Reson Imaging       Date:  2013-04-04       Impact factor: 4.813

10.  Combat-related blast exposure and traumatic brain injury influence brain glucose metabolism during REM sleep in military veterans.

Authors:  Ryan P J Stocker; Marissa A Cieply; Benjamin Paul; Hassen Khan; Luke Henry; Anthony P Kontos; Anne Germain
Journal:  Neuroimage       Date:  2014-06-02       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.